RxDoctor Payments Data

Daniel Sleiter

Pediatrics · Des Moines, IANPI 1447242359

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (41.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Ultragenyx Pharmaceutical Inc. at 55.4% of the total. Reporting peaked in 2022 at $23,700 and has fallen 99.6% since, to $93 in 2025. Among pediatrics clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,690in general payments, 2019–2025

Across 124 payments — averaging $352.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ultragenyx Pharmaceutical Inc.$24K
  • Dexcom, Inc.$18K
  • Abbott$788
  • AbbVie$150
  • Ascendis Pharma Endocrinology Inc$143
  • Sequel Med Tech, LLC$93
  • plus $308 from 9 others

What the payments were for

  • Consulting fees$16,33037%
  • Speaking & faculty fees$18,07041%
  • Travel & lodging$7,34717%
  • Food & beverage$1,9434%

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,690 in reported general payments places this provider in the 95th percentile of 308 pediatrics providers in Iowa.

See all pediatrics providers in Iowa

Other pediatrics in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →